Miraculins Announces Election of Directors
2014年5月29日 - 7:30PM
Marketwired
Miraculins Announces Election of Directors
WINNIPEG, MANITOBA--(Marketwired - May 29, 2014) - Miraculins
Inc. (TSX-VENTURE:MOM) (the "Company"), a medical diagnostic
company focused on acquiring, developing and commercializing
diagnostic tests and risk assessment technologies for unmet
clinical needs, announces that at today's annual and special
meeting of shareholders (the "Meeting"), Harry Bloomfield,
Christopher Moreau, William Roberts and Michael Stasiuk were
reelected as directors of the Company to hold office until the next
annual meeting of shareholders, or until their successors are duly
elected or appointed. James Mellon had advised the Company prior to
the Meeting that he would not be standing for reelection.
Neither the TSX
Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this
release.
Miraculins Inc.Christopher J. MoreauPresident &
CEO204-477-7599204-453-1546info@miraculins.comwww.miraculins.com
Miraculins Inc. (TSXV:MOM)
過去 株価チャート
から 5 2024 まで 6 2024
Miraculins Inc. (TSXV:MOM)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about (トロントベンチャー取引所): 0 recent articles
その他のMiraculins Inc.ニュース記事